Press enter to begin your search

Open Orphan - Early adopters signed for Genomic Health DataBANK

ORPH
Mon, 25 Nov 2019, 08:45 GMT

Maurice Treacy, Chief Commercial Officer of Open Orphan, provides an update on the signing of five pharmaceutical and biotechnology companies as early adopters of its Genomic Health DataBANK platform. The platform is expected to be completed and rolled out in Q1 2020.

Maurice Treacy
Director
ORPH
5dd80ead8e9f38744a57e605
SHOW MORE
FROM THIS COMPANY
Open Orphan - Early adopters signed for Genomic Health DataBANK
ORPH Mon, 25 Nov 2019, 08:45 GMT

Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug-focused pharma services company by a management team with extensive industry and financial expertise.

Industry: Health Care

Contact: +353 (01) 6440007
Dublin 2, Ireland
https://www.openorphan.com

Maurice Treacy, Chief Commercial Officer of Open Orphan, provides an update on the signing of five pharmaceutical and biotechnology companies as early adopters of its Genomic Health DataBANK platform. The platform is expected to be completed and rolled out in Q1 2020.

Maurice Treacy
Director
POWERED BY